Azeliragon-d9 (TTP488-d9) is the deuterium labeled Azeliragon (HY-50682). Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimers disease (AD)[1]. Azeliragon also can cross the blood-brain barrier (BBB)[2].
Molecular Weight:
541.17
Formula:
C32H29D9ClN3O2
Target:
Amyloid-beta,Isotope-Labeled Compounds
Application Notes:
MCE Product type: Isotope-Labeled Compounds
* VAT and and shipping costs not included. Errors and price changes excepted
